Intestinal fatty acid absorption

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 9, Issue 1, 2009, Pages 60-73

  Ji, Yong ^a   Li, Xiaoming ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acyl CoA cholesterol acyltransferase; Eenterocytes; Fatty acid binding protein; Lipase; Pluronic 81; Transporter

Indexed keywords

ACID LIPASE; ACYLGLYCEROL; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID BINDING PROTEIN; MONOACYLGLYCEROL; TAUROCHENODEOXYCHOLIC ACID; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ABETALIPOPROTEINEMIA; CELL METABOLISM; CHOLESTEROL TRANSPORT; DIGESTION; FABRY DISEASE; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HUMAN; INTESTINE CELL; INTESTINE MOTILITY; LIPID ABSORPTION; LIPID METABOLISM; LIPID SOLUBILITY; LIPID TRANSPORT; LIPID VESICLE; MICELLE; NONHUMAN; OBESITY; PANCREAS SECRETION; PROTEIN FUNCTION; REVIEW; SMALL INTESTINE ABSORPTION;

EID: 70350026102     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152209788009832     Document Type: Review

References (175)

1. Borgstrom, B. Luminal digestion of fats. In The exocrine pancreas, Go V.L., Ed.; Raven Press: New York (NY), 1986; pp. 361-373.
2. Carey, M.C.; Small, D.M. The characteristics of mixed micellar solution with particular reference to bile. Am. J. Med., 1970, 49, 590-608.
3. Dawson, P.A.; Rudel, L.L. Intestinal cholesterol absorption. Curr. Opin. Lipidol., 1999, 10, 315-320.
4. Plösch, T.; Kosters, A.; Groen, A.K.; Kuipers, F. The ABC of hepatic and intestinal cholesterol transport. Handb. Exp. Pharmacol., 2005, 170, 465-82.
5. Wang, D.Q. Regulation of intestinal cholesterol absorption. Annu. Rev. Physiol., 2007, 69, 221-48.
6. Kannel, W.B.; Dawber, T.R.; Friedman, G.D.; Glennon, W.E.; McNamara, P.M. Risk factors in coronary heart disease: an evaluation of several serum lipids as predictors of CHD. Ann. Intern. Med., 1964. 61, 888-899.
7. Levy, D.; Kannel, W.B. Cardiovascular risks: New insights from Framingham. Am. Heart J., 1988, 116, 266-272.
8. Austin, M.A. Plasma triglyceride and coronary heart disease. Arterioscler. Thrombo., 1991, 11, 2-14.
9. Benyen, A.C.; Kritchevsky, D. Dietary fat and serum cholesterol. In Nutritional Effects on Cholesterol Metabolism, Benyen, A.C., Ed.; Voorthuizen: Transmodial, 1986; pp. 1-10.
10. Valenzuela, A.; Morgado, N. Trans fatty acid isomers in human health and in the food industry. Biol. Res., 1999, 32, 273-287.
11. Katan, M.B. Trans fatty acids and plasma lipoproteins. Nutr. Rev., 2000, 58, 188-191.
12. Babayan, V.K. Medium chain triacylglycerols and structured lipids. Lipids, 1987, 22, 417-420.
13. Mascioli, E.A.; Babayan, V.K.; Bistrian, B.R.; Blackburn, G.L. Novel triacylglycerols for special medical purposes. J. Parenter. Enteral. Nutr., 1988, 2, 127S-132S.
14. Heird, W.C.; Grundy, S.M.; Hubbard, V.S. Structured lipids and their use in clinical nutrition. Am. J. Clin. Nutr., 1986, 43, 320-324.
15. Bell, S.J.; Bradley, D.; Forse, R.A.; Bistrian, B. The new dietary fats in health and disease. J. Am. Diet. Assoc., 1997, 97, 280-286.
16. Mu, H.; Porsgaard, T. The metabolism of structured triacylglycerols. Prog. Lipid Res. 2005, 6, 430-448.
17. McKenna, M.C.; Hubbard, V.S.; Bieri, J.G. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. J. Pediatr. Gastroenterol. Nutr., 1985, 4, 45-51.
18. Hubbard, V.S.; McKenna, M.C. Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis. Lipids, 1987, 22, 424-428.
19. Mok, K.T.; Maiz, A.; Yamazaki, K.; Sobrado, J.; Babayan, V.K.; Moldawer, L.L.; Bristrian, B.R.; Blackburn, G.L. Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat. Metabolism, 1984, 33, 910-915.
20. Swenson, E.S.; Selleck, K.M.; Babyan, V.K.; Blackburn, G.L.; Bistrian, B.R. Persistence of metabolic effects after long-term oral feeding of a structured triglyceride derived from medium-chain triglyceride and fish oil in burned and normal rats. Metabolism, 1991, 40, 484-490.
21. Tso, P.; Lee, T.; DeMichelem, S.J. Lymphatic absorption of structured triglycerides vs. physical mix in a rat model of fat malabsorption. Am. J. Physiol., 1999, 277, G333-G340.
22. Tso, P.; Lee, T.; DeMichele, J. Randomized structured triglycerides increase lymphatic absorption of tocopherol and retinol compared with the equivalent physical mixture in a rat model of fat malabsorption. J. Nutr., 2001, 131, 2157-2163.
23. Moreau, H.; Laugier, R.; Gargouri, Y.; Ferrato, F.; Verger, R. Human preduodenal lipase is entirely of gastric fundic origin. Gastroenterology, 1988, 95, 1221-1226.
24. Abrams, C.K.; Hamosh, M.; Lee, T.C.; Ansher, A.F.; Collen, M.J.; Lewis, J.H.; Benjamin, S.B.; Hamosh, P. Gastric lipase: localization in the human stomach. Gastroenterology, 1988, 95, 1460-1464.
25. Hamosh, M.; Scanlon, J.W.; Ganot, D.; Likel, M.; Scanlon, K.B.; Hamosh, P. Fat digestion in the newborn: characterization of lipase in gastric aspirates of premature and term infants. J. Clin. Invest., 1981, 67, 838-846.
26. Liao, T.H.; Hamosh, P.; Hamosh, M. Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr. Res., 1984, 18, 402-409.
27. Cohen, M.; Morgan, R.G.H.; Hofmann, A.F. Lipolytic activity of human gastric and duodenal juice against medium- and long-chain triglycerides. Gastroenterology, 1971, 60, 1-15.
28. Grand, R.J.; Watkins, J.B.; Torti, F.M. Development of the human gastrointestinal tract: a review. Gastroenterology, 1976, 70, 790-810.
29. Ross, C.A.C. Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis. Arch. Dis. Child., 1955, 30, 316-321.
30. Armand, M.; Hamosh, M.; Philpott, J.R.; Resnik, A.K.; Rosenstein, B.J.; Hamosh, A.; Perman, J.A.; Hamosh, P. Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion. Pediatr. Res., 2004, 55(3), 457-465.
31. Senior, J.R. Intestinal absorption of fats. J. Lipid Res., 1964, 5, 495-521.
32. Carey, M.C.; Small, D.M.; Bliss, C.M. Lipid digestion and absorption. Ann. Rev. Physiol., 1983, 45, 651-677.
33. Sarda, L.; Desnuelle, P. Action de la lipase pancreatique sur les esters en emulsion. Biochim. Biophys. Acta, 1958, 30, 513-521.
34. Benzonana, G.; Desnuelle, P. Etude cinetique de l'action de la lipase pancreatique sur des triglycerides en emulsion. Essai d'une enzymologie en milieu heterogene. Biochim. Biophys. Acta, 1965, 105, 121-136.
35. Desnuelle, P. The lipase-colipase system. In Lipid absorption: biochemical and clinical aspects, Rommel, K.; Goebell, H.; Bohmer, R.; Eds.; MTP Press Ltd.: London, 1976; pp. 23-37.
36. Schönheyder, F.; Volquartz, K. Gastric lipase in man. Acta Physiol. Scand., 1946, 11, 349-360.
37. Verger, R. Enzyme kinetics of lipolysis. Methods Enzymol., 1980, 64, 340-392.
38. James, L.K.; Augustein, L.G. Absorption of enzymes at interfaces: file formation and the effect on activity. Adv. Enzymol., 1966, 28, 1-40.
39. McLaren, A.D.; Packer, L. Some aspects of enzyme reactions in heterogeneous systems. Adv. Enzymol., 1970, 33, 245-308.
40. Brockerhoff, H. Substrate specificity of pancreatic lipase. Biochim. Biophys. Acta, 1968, 159, 296-303.
41. Mattson, F.H.; Beck, L.W. The specificity of pancreatic lipase on the primary hydroxyl groups of glycerides. J. Biol. Chem., 1956, 219, 735-740.
42. Simmonds, W.J. Fat absorption and chylomicron formation. In Blood lipids and lipoproteins: quantitation, composition and metabolism, Nelson, G.J., Ed.; Wiley (Interscience): New York (NY), 1972; pp. 705-743.
43. DiMagno, E.P.; Go, V.L.; Summerskill, W.H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N. Engl. J. Med., 1973, 288, 813-815.
44. Carrière, F.; Grandval, P.; Gregory, P.C.; Renou, C.; Henniges, F.; Sander-Struckmeier, S.; Laugier, R. Does the pancreas really produce much more lipase than required for fat digestion? JOP, 2005, 6(3), 206-15.
45. Borgstrom, B. On the mechanism of the hydrolysis of glycerides by pancreatic lipase. Acta Chem. Scand., 1953, 7, 557-560.
46. Mattson, F.H.; Volpenhein, R.A. The digestion and absorption of triglycerides. J. Biol. Chem., 1964, 239, 2772-2777.
47. Mattson, F.H.; Volpenhein, R.A. Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J. Lipid Res., 1968, 9, 79-84.
48. Borgstrom, B. Influence of bile salt, pH, and time on the action of pancreatic lipase; physiological implications. J. Lipid Res., 1964, 5, 522-531.
49. Hofmann, A.F.; Borgstrom, B. Hydrolysis of long-chain monoglycerides in micellar solution by pancreatic lipase. Biochim. Biophys. Acta, 1963, 70, 317-331.
50. Patton, J.S. Gastrointestinal lipid digestion. In Physiology of the gastrointestinal tract, Johnson, L.E., Ed.; Raven Press: New York (NY), 1981; pp.1123-1146.
51. Vandermeers, A.; Christophe, J. Alpha-amylase et lipsae du pancreas de rat. Purification chromatographique, recherche du poids moleculaire et composition e acides amines. Biochim. Biophys. Acta, 1968, 154, 110-129.
52. Vandermeers, A.; Vandermeers-Piret, M.C.; Rathe, J.; Christophe, J. On human pancreatic triacylglycerol lipase: isolation and some properties. Biochim. Biophys. Acta, 1974, 370, 257-268.
53. Julien, R.; Canioni, P.; Rathelot, J.; Sarda, L.; Plummer, Jr., T.H. Studies on bovine pancreatic lipase and colipase. Biochim. Biophys. Acta, 1972, 280, 215-224.
54. Rathelot, J.; Julien, R.; Bosc-Bierne, P.; Gargouri, Y.; Canioni, P.; Sarda, L. Horse pancreatic lipase. Interaction with colipase from various species. Biochimie, 1981, 63, 227-234.
55. De Caro J.; Boudouard, M.; Bonicel, J.; Guidoni, A.; Desnuelle, P.; Rovery, M. Porcine pancreatic lipase. Completion of the primary structure. Biochim. Biophys. Acta, 1981, 671, 129-138.
56. B. J. Biol. Chem., 1973, 248, 7865-7869.
57. Rathelot, J.; Canioni, P.; Bosc-Bierne, I.; Sarda, L.; Kamoun, A.; Kaptein, R.; Cozzone, P.J. Limited trypsinolysis of porcine and equinine colipases. Biochim. Biophys. Acta, 1981, 671, 155-163.
58. Chapus, C.; Semeriva, M. Mechanism of pancreatic lipase action. 1. Interfacial activation of pancreatic lipase. Biochemistry, 1976, 15, 4988-4991.
59. Morgan, R.G.H.; Barrowman, J.; Borgstrom, B. The effect of sodium taurodeoxycholate and pH on the gel filtration behaviour of rat pancreatic protein and lipases. Biochim. Biophys. Acta, 1969, 175, 65-75.
60. Erlanson, C.; Borgstrom, B. Purification and further characterization of colipase from porcine pancreas. Biochim. Biophys. Acta, 1972, 271, 400-412.
61. Sternby, B.; Borgstrom, B. Purification and characterization of human pancreatic colipase. Biochim. Biophys. Acta, 1979, 572, 235-243.
62. Maylie, M.F., Charles, M.; Gache, C.; Desnuelle, P. Isolation and partial identification of a pancreatic colipase. Biochim. Biophys. Acta, 1971, 229, 286-289.
63. Maylie, M.F.; Charles, M.; Gache, C.; Desnuelle, P. On porcine pancreatic colipase: large scale purification and some properties. Biochem. Biophys. Res. Commun., 1973, 52, 291-297.
64. Erlanson-Albertsson, C. Pancreatic colipase. Structural and physiological aspects. Biochim. Biophys. Acta, 1992, 1125, 1-7.
65. Freie, A.B.; Ferrato, F.; Carrière, F.; Lowe, M.E. Val-407 and Ile-408 in the beta5′-loop of pancreatic lipase mediate lipase-colipase interactions in the presence of bile salt micelles. J. Biol. Chem., 2006, 281(12), 7793-7800.
66. Patton, J.S.; Albertsson, P.A.; Erlanson, C.; Borgstrom, B. Binding of porcine pancreatic lipase and colipase in the absence of substrate studies by two-phase partition and affinity chromatography. J. Biol. Chem., 1978, 253, 4195-4202.
67. Hofmann, A.F.; Borgstrom, B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc., 1962, 21, 43-50.
68. Hofmann, A.F.; Borgstrom, B. The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest., 1964, 43, 247-257.
69. Dietschy, J.M.; Sallee, V.L.; Wilson, F.A. Unstirred water layers and absorption across the intestinal mucosa. Gastroenterology, 1971, 61, 932-934.
70. Wilson, F.A.; Sallee, V.L.; Dietschy, J.M. Unstirred water layers in intestine: rate determinant of fatty acid from micellar solutions. Science, 1971, 174, 1031-1033.
71. Westergaard, H.; Dietschy, J.M. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J. Clin. Invest., 1976, 58, 97-108.
72. Swell, L.; Flick, D.F.; Field, Jr., H.; Treadwell, C.R. Influence of dietary bile salts on blood cholesterol levels. Proc. Soc. Exp. Biol. Med., 1953, 84, 428-431.
73. Gallo-Torres, H.E.; Miller, O.N.; Hamilton, J.G. Further studies on the role of bile salts in cholesterol esterification and absorption from the gut. Arch. Biochem. Biophys., 1971, 143, 22-36.
74. Watt, S.M.; Simmonds, W.J. The specificity of bile salts in the intestinal absorption of micellar cholesterol in the rat. Clin. Exp. Pharmacol. Physiol., 1976, 3, 305-322.
75. Reynier, M.O.; Montet, J.C.; Gerolami, A.; Marteau, C.; Crotte, C.; Montet, A.M.; Mathieu, S. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J. Lipid Res., 1981, 22, 467-473.
76. Cohen, B.I.; Raicht, R.F.; Mosbach, E.H. Sterol metabolism studies in the rat. Effects of primary bile acids (sodium taurochenodeoxycholate and sodium taurocholate) on sterol metabolism. J. Lipid Res., 1977, 18, 223-231.
77. Watt, S.M.; Simmonds, W.J. Effects of four taurine-conjugated bile acids on mucosal uptake and lymphatic absorption of cholesterol in the rat. J. Lipid Res., 1984, 25, 448-455.
78. Porter, H.P.; Saunders, D.R. Isolation of the aqueous phase of human intestinal contents during the digestion of a fatty meal. Gastroenterology, 1971, 60, 997-1007.
79. Patton, J.S.; Carey, M.C. Watching fat digestion. Science, 1979, 204, 145-148.
80. Hernell, O.; Staggers, J.E.; Carey, M.C. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry., 1990, 29, 2041-2056.
81. Mansbach, C.M.; Newton, D.; Stevens, R.D. Fat digestion in patients with bile acid malabsorption but minimal steatorrhea. Dig. Dis. Sci., 1980, 25, 353-362.
82. Porter, H.P., Saunders, D.R.; Tytgat, G.; Brunster, O.; Rubin, C.E. Fat absorption in bile fistula man. A morphological and biochemical study. Gastroenterology, 1971, 60, 1008-1019.
83. Setchell, K.D.; Heubi, J.E. Defects in bile acid biosynthesis - diagnosis and treatment. J. Pediatr. Gastroenterol. Nutr., 2006, 43 (Suppl 1), S17-S22
84. Thomson A.B.R; Keelan, M.; Garg, M.L.; Clandinin, M.T. Intestinal aspects of lipid absorption. Can. J. Physiol. Pharmacol., 1989, 67, 179-191.
85. Strauss, E.W. Electron microscopic study of intestinal fat absorption in vitro from mixed micelles containing linolenic acid, monoolein, and bile salt. J. Lipid Res., 1966, 7, 307-323.
86. Stremmel, W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Invest., 1988, 82, 2001-2010.
87. Chow, S.L.; Hollander, D. A dual, concentration-dependent absorption mechanism of linoleic acid by rat jejunum in vitro. J. Lipid Res., 1979, 20, 349-356.
88. Stremmel, W.; Lotz, G.; Strohmeyer, G.; Berk, P.D. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J. Clin. Invest., 1985, 75, 1068-1076.
89. Berk, P.D.; Wada, H.; Horio, Y.; Potter, B.J.; Sorrentino, D.; Zhou, S.L.; Isola, L.M.; Stump, D.; Kiang, C.L.; Thung, S. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc. Natl. Acad. Sci. USA, 1990, 87, 3484-3488.
90. Harmon, C.M.; Luce, P.; Beth, A.H.; Abumrad, N.A. Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport. J. Membr. Biol., 1991, 121, 261-268.
91. Abumrad, N.A.; el-Maghrabi, M.R.; Amri, E.Z.; Lopez, E.; Grimaldi, P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem., 1993, 268, 17665-17668.
92. Van Nieuwenhoven, F.A.; Verstijnen, C.P.H.J.; Abumrad, N.A.; Willemsen, P.H.M.; Van Eys, G.J.J.M.; Van Der Vusse, G.J.; Glatz, J.F.C. Putative membrane fatty acid-translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun., 1995, 207, 747-752.
93. Spitzberg, V.L.; Matitashivili, E.; Gorewit, R.C. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in bovine mammary gland. Eur. J. Biochem., 1995, 230, 872-878.
94. Poirier, H.; DeGrace, P.; Niot, I.; A. Bernard; Besnard, P. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur. J. Biochem., 1996, 238, 368-373.
95. Abumrad, N.A.; Sfeir, Z.; Connelly, M.A.; Coburn, C. Lipid transporters: membrane transport systems for cholesterol and fatty acids. Curr. Opin. Clin. Nutr. Metab. Care, 2000, 3, 255-262.
96. Nauli, A.M.; Nassir, F.; Zheng, S.; Yang, Q.; Lo, C.M.; Vonlehmden, S.B.; Lee, D.; Jandacek, R.J.; Abumrad, N.A.; Tso, P. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology, 2006, 131(4), 1197-207.
97. Schaffer, J.E.; Lodish, H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell, 1994, 79, 427-436.
98. Stahl, A.; Hirsch, D.J.; Gimeno, R.E.; Punreddy, S.; Ge, P.; Watson, N.; Patel, S.; Kotler, M.; Raimondi, A.; Tartaglia, L.A.; and Lodish, H.F. Identification of the major intestinal fatty acid transport protein. Mol. Cell, 1999, 4, 299-308.
99. Moulson, C.L.; Martin, D.R.; Lugus, J.J.; Schaffer, J.E.; Lind, A.C.; Miner, J.H. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc. Natl. Acad. Sci. USA, 2003, 100(9), 5274-5279.
100. Herrmann, T.; Gröne, H.J.; Langbein, L.; Kaiser, I.; Gosch, I.; Bennemann, U.; Metzger, D.; Chambon, P.; Stewart, A.F.; Stremmel, W. Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency. J. Invest. Dermatol., 2005, 125(6), 1228-1235.
101. Hall, A.M.; Wiczer, B.M.; Herrmann, T.; Stremmel, W.; Bernlohr, D.A. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice. J. Biol. Chem., 2005, 280(12), 11948-11954.
102. Shim, J.; Moulson, C.L.; Newberry, E.P.; Lin, M.H.; Xie, Y.; Kennedy, S.M.; Miner, J.H.; Davidson, N.O. Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice. J. Lipid Res., 2009, 50, 491-500.
103. Chow, S.L.; Hollander, D.; Linoleic acid absorption in the unanesthetized rate: mechanism of transport and influence of luminal factors on absorption. Lipids, 1979, 14(4), 378-85.
104. Ockner, R.K.; Manning, J.A. Fatty acid binding protein in small intestine. Identification, isolation and evidence for its role in cellular fatty acid transport. J. Clin. Invest., 1974, 54, 326-338.
105. Ockner, R.K.; Manning, J.A.; Poppenhausen, R.B.; Ho, W.K. A binding protein for fatty acids in cytosol intestinal mucosa, liver, myocardium, and other tissues. Science, 1972, 177, 56-58.
106. Glatz, J.F.C.; Veerkamp, J.H. Intracellular fatty acid-binding proteins. Int. J. Biochem., 1985, 17, 13-22.
107. Bass, M.M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int. Rev. Cytol., 1988, 111, 143-184.
108. Bansal, M.P.; Cook, R.G.; Danielson, K.G.; Medina, D. A 14-kilodalton selenium-binding protein in mouse liver is fatty acid-binding protein. J. Biol. Chem., 1989, 264, 13780-13784.
109. Cistola, D.P.; Sacchettini, J.C.; Banaszak, L.J.; Walsh, M.T.; Gordon, J.I. Fatty acid interactions with rat intestinal and liver fatty acid-binding proteins expressed in Escherichia coli. A comparative 13C NMR study. J. Biol. Chem., 1989, 264, 2700-2710.
110. Storch, J.; Thumser, A.E. The fatty acid transport function of fatty acid-binding proteins. Biochim. Biophys. Acta, 2000, 1486, 28-44.
111. Shaughnessy, S.; Smith, E.R.; Kodukula, S.; Storch, J.; Fried, S.K. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte fatty acid binding protein. Diabetes, 2000, 49, 904-911.
112. Vassileva, G.; Huwyler, L.; Poirier, K.; Agellon, L.B.; Toth, M.J. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J., 2000, 14, 2040-2046.
113. Agellon, L.B.; Toth, M.J.; Thomson, A.B. Intracellular lipid binding proteins of the small intestine. Mol. Cell Biochem., 2002, 239, 79-82.
114. Newberry, E.P.; Xie, Y.; Kennedy, S.M.; Luo, J.; Davidson, N.O. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology, 2006, 44, 1191-205.
115. Johnston, J.M. Triglyceride biosynthesis in the intestinal mucosa. In Lipid absorption: biochemical and clinical aspects, Rommel, K., Goebell, H., Bohmer, R., Eds.; MTP Press Ltd.: London, 1976; pp. 85-94.
116. Kuksis, A.; Manganaro, F. Biochemical characterization and purification of intestinal acylglycerol acyltransferases. In Fat absorption, Kuksis, A., Ed.; CRC Press: Boca Raton (FL), 1986; pp. 233-259.
117. Rao, G.A.; Johnston, J.M. Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim. Biophys. Acta, 1966, 125, 465-473.
118. Lehner, R.; Kuksis, A. Triacylglycerol synthesis by purified triacylglycerol synthetase of rat intestinal mucosa. Role of acyl-CoA acyltransferase. J. Biol. Chem., 1995, 270, 13630-13636.
119. Smith, S.J.; Cases, S.; Jensen, D.R.; Chen, H.C.; Sande, E.; Tow, B.; Sanan, D.A.; Raber, J.; Eckel, R.H.; Farese, Jr., R.V. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet., 2000, 25, 87-90.
120. Bell, R.M.; Ballas, L.M.; Coleman, R.A. Lipid topogenesis. J. Lipid Res., 1981, 22, 391-403.
121. Atkinson, D.; Small, D.M. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu. Rev. Biophys. Biophys. Chem., 1986, 15, 403-56.
122. Wetterau, J.R.; Zilversmit, D.B. A triglyceride and cholesteryl ester transfer protein associated with liver microsomes. J. Biol. Chem., 1984, 259, 10863-10866.
123. Wetterau, J.R.; Zilversmit, D.B. Purification and characterization triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem. Phys. Lipids, 1985, 38, 205-222.
124. Wetterau, J.R.; Zilversmit, D.B. Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues. Biochim. Biophys. Acta, 1986, 875, 610-617.
125. Polheim, D.; David, J.S.K.; Schultz, F.M.; Wylie, M.B.; Johnston, J.M. Regulation of triglyceride biosynthesis in adipose and intestinal tissue. J. Lipid Res., 1973, 14, 415-421.
126. Yen, C.L.; Stone, S.J.; Koliwad, S.; Harris, C.; Farese, Jr., R.V. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res., 2008, 49, 2283-301.
127. Shi Y, Cheng D. Beyond Triglyceride Synthesis: The Dynamic Functional Roles of MGAT and DGAT Enzymes in Energy Metabolism. Am. J. Physiol. Endocrinol. Metab., 2008.
128. Buhman, K.K.; Smith, S.J.; Stone, S.J.; Repa, J.J.; Wong, J.S.; Knapp, Jr., F.F.; Burri, B.J.; Hamilton, R.L.; Abumrad, N.A.; Farese, Jr., R.V. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J. Biol. Chem., 2002, 277, 25474-9.
129. Yen, C.L.; Monetti, M.; Burri, B.J.; Farese, Jr., R.V. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. J. Lipid Res., 2005, 46, 1502-11.
130. Cao, J.; Cheng, L.; Shi, Y. Catalytic properties of MGAT3, a putative triacylgycerol synthase. J. Lipid Res., 2007, 48, 583-591.
131. Wu, A.L.; Clark, S.B.; Holt, P.R. Transmucosal triglyceride transport rates in proximal and distal rat intestine in vivo. J.Lipid Res., 1975, 16, 251-257.
132. Wu, A.L.; Clark, S.B.; Holt, P.R. Composition of lymph chylomicrons from proximal or distal rat small intestine. Am. J. Clin. Nutr., 1980, 33, 582-589.
133. Hussain, M.M. A proposed model for the assembly of chylomicrons. Atherosclerosis, 2000, 148, 1-15.
134. Murphy, S.; Albright, E.; Mathur, S.N.; Field, F.J. Effect of eicosapentaenoic acid on triacylglycerol transport in CaCo-2 cells. Biochim. Biophys. Acta, 1990, 1045, 147-155.
135. Kam, N.T.; Albright, E.; Mathur, S.N.; Field, F.J. Inhibition of acylcoenzyme A:cholesterol acyltransferase activity in CaCo-2 cells results in intracellular triglyceride accumulation. J. Lipid Res., 1989, 30, 371-377.
136. Kam, N.T.; Albright, E.; Mathur, S.N.; Field, F.J. Effect of lovastatin on acyl-CoA: cholesterol acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells. Biochem. J., 1990, 272, 427-433.
137. Traber, M.G.; Kayden, H.J.; Rindler, M.J. Polarized secretion of newly synthesized lipoproteins by the Caco-2 human intestinal cell line. J. Lipid Res., 1987, 28, 1350-1363.
138. Murphy, S.; Albright, E.; Mathur, S.N.; Davidson, N.O.; Field, F.J. Apolipoprotein B mRNA abundance is decreased by eicosapentaenoic acid in CaCo-2 cells. Effect on the synthesis and secretion of apolipoprotein B. Arterioscler. Thromb., 1992, 12, 691-700.
139. Ockner, R.K.; Hughes, F.B.; Isselbacher, K.J.Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J. Clin. Invest., 1969, 48, 2367-2373.
140. Tso, P.; Drake, D.S.; Black, D.D.; Sabesin, S.M. Evidence for separate pathways of chylomicron and very low density lipoprotein assembly and transport by rat small intestine. Am. J. Physiol., 1984, 247, G599-G610.
141. Zilversmit, D.B. The composition and structure of lymph chylomicrons in dog, rat, and man. J. Clin. Invest., 1965, 44, 1610-1622.
142. Lindgren, F.T.; Jensen, L.C.; Hatch, F.T. The isolation and quantitative analysis of serum lipoproteins. In Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism, Nelson, G.J., Ed.; Wiley (Interscience): New York, 1972; pp. 181-274.
143. Mahley, R.W.; Bennett, B.D.; Morre, D.J.; Gray, M.E.; Thistlethwaite, W.; LeQuire, V.S. Lipoproteins associated with Golgi apparatus isolated from epithelial cells of rat small intestine. Lab. Invest., 1971, 25, 435-444.
144. Vahouny, G.V.; Blendermann, E.M.; Gallo, L.L.; Treadwell, C.R. Differential transport of cholesterol and oleic acid in lymph lipoproteins: sex differences in puromycin sensitivity. J. Lipid Res., 1981, 21, 415-424.
145. Tso, P.; Balint, J.A.; Bishop, M.B.; Rodgers, J.B. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am. J. Physiol., 1981, 241, G487-G497.
146. Tso, P.; Balint, J.A.; Rodgers, J.B. Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat. Am. J. Physiol., 1980, 239, G348-G353.
147. Tso P.; Kendrick, H.; Balint, J.A.; Simmonds, W.J. Role of biliary phosphatidylcholine in the absorption and transport of dietary triolein in the rat. Gastroenterology, 1981, 80, 60-65.
148. Nutting, D.; Hall, J.; Barrowman, J.A.; Tso, P. Further studies on the mechanism of inhibition of intestinal chylomicron transport by Pluronic L-81. Biochim. Biophys. Acta, 1989, 22, 357-362.
149. Hussain, M.M.; Kancha, R.K.; Zhou, Z.; Luchoomun, J.; Zu, H.; Bakillah, A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta, 1996, 1300, 151-170.
150. Trotter, P.J.; Storch, J. Fatty acid esterification during differentiation of the human intestinal cell line Caco-2. J. Biol. Chem., 1993, 268, 10017-10023.
151. Mansbach II, C.M.; Gorelick, F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 293, G645-G650.
152. Neeli, I.; Siddiqi, S.A.; Siddiqi, S.; Mahan, J.; Lagakos, W.S.; Binas, B.; Gheyi, T.; Storch, J.; Mansbach II, C.M. Liver fatty acid-binding protein initiates budding of the pre-chylomicron transport vesicles from intestinall endoplasmic reticulum. J. Biol. Chem., 2007, 282, 17974-17984.
153. Edge, S.B.; Hoeg, J.M.; Schneider, P.D.; Brewer, Jr., H.B. Apolipoprotein B synthesis in humans: liver synthesizes only apolipoprotein B-100. Metabolism, 1985, 34, 726-730.
154. Glickman, R.M.; Rogers, M.; Glickman, J.N. Apolipoprotein B synthesis by human liver and intestine in vitro. Proc. Natl. Acad. Sci. USA, 1986, 83, 5296-5300.
155. Glickman, R.M.; Glickman, J.N.; Magun, A.; Brin, M. Apolipoprotein synthesis in normal and abetalipoproteinemic intestinal mucosa. Gastroenterology, 1991, 101, 749-755.
156. Chen, S.H.; Habib, G.; Yang, C.Y.; Gu, Z.W.; Lee, B.R.; Weng, S.A.; Silberman, S.R.; Cai, S.J.; Deslypere, J.P.; Rosseneu, M.; Gotto, Jr., A.M.; Li, W.H.; Chan, L. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science, 1978, 238, 363-366.
157. Powell, L.M.; Wallis, S.C.; Pease, R.J.; Edwards, Y.H.; Knott, T.J.; Scott, J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell, 1987, 50, 831-840.
158. Kane, J.P; Hardman, D.A.; Paulus, H.E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc. Natl. Acad. Sci. USA, 1980, 77, 2465-2469.
159. Cardin, A.D.; Witt, K.R.; Barnhart, C.L.; Jackson, R.L. Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. Biochemistry, 1982, 21, 4503-4511.
160. Martins, J.J.; Sainsbury, A.J.; Mamo, J.C.; Redgrave, T.G. Lipid and apolipoprotein B-48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia, 1994, 37, 238-246.
161. Hayashi, H.; Fujimoto, K.; Cardelli, J.A.; Nutting, D.F.; Bergstedt, S.; Tso, P. Fat feeding increases size, but not number of chylomicrons produced by small intestine. Am. J. Physiol., 1990, 259, G709-G719.
162. Davidson, N.O.; Magun, A.M.; Brasitus, T.A.; Glickman, R.M. Intestinal apolipoprotein A-I and B-48 metabolism: effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J. Lipid Res., 1987, 28, 388-402.
163. Isselbacher, K.J.; Scheig, R.; Plotkin, G.R.; Caulfield, J.B. Congenital beta-lipoprotein deficiency: An hereditary disorder involving a defect in the absorption and transport of lipids. Medicine (Baltimore), 1964, 43, 347-61.
164. Ways, P.O.; Parmentier, C.M.; Kayden, H.J.; Jones, J.W.; Saunders, D.R.; Rubin, C.E. Studies on the absorptive defect for triglyceride in abetalipoproteinemia. J. Clin. Invest., 1967, 46, 35-46.
165. Ohashi, K.; Ishibashi, S.; Osuga, J.; Tozawa, R.; Harada, K.; Yahagi, N.; Shionori, F.; Iizuka, Y.; Tamura, Y.; Nagai, R.; Illingworth, D.R.; Gotoda, T.; Yamada, N. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J. Lipid Res., 2000, 41, 1199-1204.
166. Wetterau, J.R.; Aggerbeck, L.P.; Bouma, M.E.; Eisenberg, C.; Munck, A.; Hermier, M.; Schmitz, J.; Gay, G.; Rader, D.J.; Gregg, R.E. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science, 1992, 258, 999-1001.
167. Gordon, D.A.; Jamil, H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta, 2000, 1486, 72-83.
168. Berriot-Varoqueaux, N.; Aggerbeck, L.P.; Samson-Bouma, M.; Wetterau, J.R. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr., 2000, 20, 663-697.
169. Sharp, D.; Ricci, B.; Kienzle, B.; Lin, M.C.; Wetterau, J.R. Human microsomal triglyceride transfer protein large subunit gene structure. Biochemistry, 1994, 33, 9057-9061.
170. Ohashi, K.; Ishibashi, S.; Osuga, J.; Tozawa, R.; Harada, K.; Yahagi, N.; Shirnoiri, F.; Iizuka, Y.; Tamura, Y.; Nagai, R.; Illingtworth, D. R.; Gotoda, T.; Yamada, N. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J. Lipid Res., 2000, 41, 1199-1204.
171. Roy, C.C.; Levy, E.; Green, P.H.R.; Sniderman, A.; Letarte, J.; Buts, J.P.; Orquin, J.; Brochu, P.; Weber, A.M.; Morin, C.L.; Marcel, Y.L.; Deckelbaum, R.J. Malabsorption, hypocholesterolemia and fat filled enterocytes with increased intestinal apo B. Chylomicron retention disease. Gastroenterology, 1987, 92, 390-399.
172. Dannoura, A.H.; Berriot-Varoqueaux, N.; Amati, P.; Abadie, V.; Verthier, N.; Schmitz, J.; Wetterau, J.R.; Samson-Bouma, M.E.; Aggerbeck, L.P. Anderson's disease: Exclusion of apolipoprotein and intracellular lipid transport genes. Arterioscler. Thromb. Vasc. Biol., 2000, 19, 2494-2508.
173. De Nigris, S.J.; Hamosh, M.; Kasbekar, D.K.; Lee, T.C.; Hamosh, P. Lingual and gastric lipases: species differences in the origin of prepancreatic digestive enzymes and species differences in localization of gastric lipases. Biochim. Biophys. Acta, 1988, 959, 38-45.
174. Kelly, K.A. Motility of the stomach and gastroduodenal junction. In Physiology of the Gastrointestinal Tract, Johnson L.R., Ed.; Raven
175. Charcosset, M.; Sassolas, A.; Peretti, N.; Roy, C.C.; Deslandres, C.; Sinnett, D.; Levy, E.; Lachaux, A. Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and functionality of Sar1b protein. Mol. Genet. Metab., 2008, 93, 74-84.